Neuraminidase inhibitors for influenza. [N Engl J Med. 2005] - PubMed

loading

Neuraminidase inhibitors for treatment of influenza A and B infections. [MMWR Recomm Rep. 1999]
Neuraminidase inhibitors for treatment of influenza A and B infections.
[No authors listed]MMWR Recomm Rep. 1999 Dec 17; 48(RR-14):1-9.
Review [Neuraminidase inhibitor]. [Nihon Rinsho. 2000]
Review [Neuraminidase inhibitor].
Kaji M. Nihon Rinsho. 2000 Nov; 58(11):2293-8.
Review Neuraminidase inhibitors: zanamivir and oseltamivir. [Ann Pharmacother. 2001]
Review Neuraminidase inhibitors: zanamivir and oseltamivir.
McNicholl IR, McNicholl JJ. Ann Pharmacother. 2001 Jan; 35(1):57-70.
[New diagnostic possibilities and medications. Fit for influenza?]. [MMW Fortschr Med. 2002]
[New diagnostic possibilities and medications. Fit for influenza?].
Wutzler P. MMW Fortschr Med. 2002 Nov 28; 144(48):18.
Neuraminidase inhibitors and relief of influenza symptoms. [S D J Med. 2000]
Neuraminidase inhibitors and relief of influenza symptoms.
Lemon M, Meade F. S D J Med. 2000 Mar; 53(3):99-100.

Occurrence and characterization of oseltamivir-resistant influenza virus in children between 2007-2008 and 2008-2009 seasons. [Korean J Pediatr. 2013]
Occurrence and characterization of oseltamivir-resistant influenza virus in children between 2007-2008 and 2008-2009 seasons.
Kim SG, Hwang YH, Shin YH, Kim SW, Jung WS, Kim SM, Oh JM, Lee NY, Kim MJ, Cho KS, et al. Korean J Pediatr. 2013 Apr; 56(4):165-75. Epub 2013 Apr 22.
Permeability enhancers dramatically increase zanamivir absolute bioavailability in rats: implications for an orally bioavailable influenza treatment. [PLoS One. 2013]
Permeability enhancers dramatically increase zanamivir absolute bioavailability in rats: implications for an orally bioavailable influenza treatment.
Holmes EH, Devalapally H, Li L, Perdue ML, Ostrander GK. PLoS One. 2013; 8(4):e61853. Epub 2013 Apr 17.
The cost effectiveness of pandemic influenza interventions: a pandemic severity based analysis. [PLoS One. 2013]
The cost effectiveness of pandemic influenza interventions: a pandemic severity based analysis.
Milne GJ, Halder N, Kelso JK. PLoS One. 2013; 8(4):e61504. Epub 2013 Apr 9.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Taxonomy via GenBank
Taxonomy records associated with the current articles through taxonomic information on related molecular database records (Nucleotide, Protein, Gene, SNP, Structure).
Protein
Protein translation features of primary database (GenBank) nucleotide records reported in the current articles as well as Reference Sequences (RefSeqs) that include the articles as references.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Neuraminidase inhibitors for influenza.
Neuraminidase inhibitors for influenza.
N Engl J Med. 2005 Sep 29 ;353(13):1363-73.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed